Mechanisms of viral membrane fusion and its inhibition - PubMed (original) (raw)
Review
Mechanisms of viral membrane fusion and its inhibition
D M Eckert et al. Annu Rev Biochem. 2001.
Abstract
Viral envelope glycoproteins promote viral infection by mediating the fusion of the viral membrane with the host-cell membrane. Structural and biochemical studies of two viral glycoproteins, influenza hemagglutinin and HIV-1 envelope protein, have led to a common model for viral entry. The fusion mechanism involves a transient conformational species that can be targeted by therapeutic strategies. This mechanism of infectivity is likely utilized by a wide variety of enveloped viruses for which similar therapeutic interventions should be possible.
Similar articles
- HIV-1 gp41: mediator of fusion and target for inhibition.
Weiss CD. Weiss CD. AIDS Rev. 2003 Oct-Dec;5(4):214-21. AIDS Rev. 2003. PMID: 15012000 Review. - The structural biology of type I viral membrane fusion.
Colman PM, Lawrence MC. Colman PM, et al. Nat Rev Mol Cell Biol. 2003 Apr;4(4):309-19. doi: 10.1038/nrm1076. Nat Rev Mol Cell Biol. 2003. PMID: 12671653 Review. - The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R. Gallo SA, et al. J Mol Biol. 2004 Jun 25;340(1):9-14. doi: 10.1016/j.jmb.2004.04.027. J Mol Biol. 2004. PMID: 15184018 - HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development.
Jacobs A, Garg H, Viard M, Raviv Y, Puri A, Blumenthal R. Jacobs A, et al. Vaccine. 2008 Jun 6;26(24):3026-35. doi: 10.1016/j.vaccine.2007.12.026. Epub 2008 Jan 10. Vaccine. 2008. PMID: 18242797 Free PMC article. - Novel therapies based on mechanisms of HIV-1 cell entry.
Kilby JM, Eron JJ. Kilby JM, et al. N Engl J Med. 2003 May 29;348(22):2228-38. doi: 10.1056/NEJMra022812. N Engl J Med. 2003. PMID: 12773651 Review. No abstract available.
Cited by
- Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins.
Gonzalez KJ, Yim KC, Blanco JCG, Boukhvalova MS, Strauch EM. Gonzalez KJ, et al. Front Immunol. 2024 Jul 24;15:1406929. doi: 10.3389/fimmu.2024.1406929. eCollection 2024. Front Immunol. 2024. PMID: 39114655 Free PMC article. - HIV-1-envelope trimer transitions from prefusion-closed to CD4-bound-open conformations through an occluded-intermediate state.
Lee M, Lu M, Zhang B, Zhou T, Katte R, Han Y, Rawi R, Kwong PD. Lee M, et al. bioRxiv [Preprint]. 2024 Jul 17:2024.07.15.603531. doi: 10.1101/2024.07.15.603531. bioRxiv. 2024. PMID: 39071380 Free PMC article. Updated. Preprint. - Fine tuning of the net charge alternation of polyzwitterion surfaced lipid nanoparticles to enhance cellular uptake and membrane fusion potential.
Homma K, Miura Y, Kobayashi M, Chintrakulchai W, Toyoda M, Ogi K, Michinishi J, Ohtake T, Honda Y, Nomoto T, Takemoto H, Nishiyama N. Homma K, et al. Sci Technol Adv Mater. 2024 Apr 10;25(1):2338785. doi: 10.1080/14686996.2024.2338785. eCollection 2024. Sci Technol Adv Mater. 2024. PMID: 38646148 Free PMC article. - SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication.
Ali H, Naseem A, Siddiqui ZI. Ali H, et al. J Clin Med. 2023 Sep 20;12(18):6079. doi: 10.3390/jcm12186079. J Clin Med. 2023. PMID: 37763019 Free PMC article. Review. - HIV Infection: Shaping the Complex, Dynamic, and Interconnected Network of the Cytoskeleton.
Cabrera-Rodríguez R, Pérez-Yanes S, Lorenzo-Sánchez I, Trujillo-González R, Estévez-Herrera J, García-Luis J, Valenzuela-Fernández A. Cabrera-Rodríguez R, et al. Int J Mol Sci. 2023 Aug 23;24(17):13104. doi: 10.3390/ijms241713104. Int J Mol Sci. 2023. PMID: 37685911 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources